Biosimilar Basics

News about biosimilars is everywhere. Sometimes you just need the basics. This recap of a recently published four-part series gets you what you need to know.

Part 1: Ground Yourself in Biosimilar Basics

What is a biosimilar? How is it different from a generic drug? Who makes biosimilars? Why do we need them? These questions and more covered in our first of a four-part series on biosimilar basics. (Read the full article)

Part 2: The Top 10 Acronyms in Drug Pipeline Content

The drug pipeline can look like alphabet soup. There are acronyms galore. Prime team provides insight on the most common acronyms in the drug pipeline. (Read the full article)

Part 3: Getting Biosimilars to Market

What does it take to get biosimilars into the market? Our team digs into the process. (Read the full article)

Part 4: How are Biobetters Different from Biosimilars?

You've heard of biosimilars. But have you heard of biobetters? Biobetters are just a nickname; they’re based on an existing biologic, but new and improved. (Read the full article)